MA26677A1 - Medicaments antiparkinsoniens. - Google Patents

Medicaments antiparkinsoniens.

Info

Publication number: MA26677A1
Authority: MA; Morocco
Prior art keywords: antiparkinsonian drugs; antiparkinsonian; drugs
Prior art date: 1998-08-18

Application number

MA25736A

Other languages

English (en)

Inventor

Buttelmann Bernd

Heitz Neidhart Marie-Paule

Pinard Emmanuel

Wyler Rene

Alanine Alexander

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-18

Filing date

1999-08-17

Publication date

2004-12-20

1999-08-17 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-12-20 Publication of MA26677A1 publication Critical patent/MA26677A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Psychology (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

MA25736A 1998-08-18 1999-08-17 Medicaments antiparkinsoniens. MA26677A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98115484		1998-08-18

Publications (1)

Publication Number	Publication Date
MA26677A1 true MA26677A1 (fr)	2004-12-20

Family

ID=8232474

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25736A MA26677A1 (fr)	1998-08-18	1999-08-17	Medicaments antiparkinsoniens.

Country Status (24)

Country	Link
US (1)	US6184236B1 (fr)
JP (1)	JP3455142B2 (fr)
KR (1)	KR100341194B1 (fr)
CN (1)	CN1141936C (fr)
AR (1)	AR021770A1 (fr)
AT (1)	ATE326219T1 (fr)
AU (1)	AU756408B2 (fr)
BR (1)	BR9903779A (fr)
CA (1)	CA2280455A1 (fr)
DE (1)	DE69931316D1 (fr)
HR (1)	HRP990256A2 (fr)
HU (1)	HUP9902737A3 (fr)
ID (1)	ID23107A (fr)
IL (1)	IL131399A0 (fr)
MA (1)	MA26677A1 (fr)
MY (1)	MY133133A (fr)
NO (1)	NO993948L (fr)
NZ (1)	NZ337243A (fr)
PE (1)	PE20000955A1 (fr)
PL (1)	PL334949A1 (fr)
SG (1)	SG82014A1 (fr)
TR (1)	TR199902015A3 (fr)
YU (1)	YU38699A (fr)
ZA (1)	ZA995212B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60112574T2 (de) *	2000-06-06	2006-06-08	Warner-Lambert Co. Llc	Bicyclische cyclohexylamine und ihre verwendung als nmda-rezeptor antagonisten
US7375136B2 (en) *	2001-03-08	2008-05-20	Emory University	pH-dependent NMDA receptor antagonists
DE10153345A1 (de) *	2001-10-29	2003-05-08	Gruenenthal Gmbh	Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen
US20070004805A1 (en) *	2005-07-01	2007-01-04	Navinta Llc	Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
MX2009014216A (es) *	2007-06-29	2010-07-05	Univ Emory	Antagonistas del receptor nmda para neuroproteccion.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4032766A1 (de)	1990-10-16	1992-04-30	Basf Ag	Phenylpiperidinoylamine und diese enthaltende arzneimittel
EP0503411B1 (fr)	1991-03-14	1995-11-29	BASF Aktiengesellschaft	N-Phénylpipéridines substituées et médicaments à partir de celles-ci
DE4117904A1 (de)	1991-05-31	1992-12-03	Basf Ag	Substituierte n-phenylpiperidine
AU715216B2 (en) *	1995-10-26	2000-01-20	Mitsubishi-Tokyo Pharmaceuticals, Inc.	Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same

1999
- 1999-08-09 DE DE69931316T patent/DE69931316D1/de not_active Expired - Lifetime
- 1999-08-09 US US09/370,602 patent/US6184236B1/en not_active Expired - Fee Related
- 1999-08-09 AT AT99115114T patent/ATE326219T1/de not_active IP Right Cessation
- 1999-08-13 IL IL13139999A patent/IL131399A0/xx unknown
- 1999-08-13 CA CA002280455A patent/CA2280455A1/fr not_active Abandoned
- 1999-08-13 NZ NZ337243A patent/NZ337243A/xx unknown
- 1999-08-13 PE PE1999000826A patent/PE20000955A1/es not_active Application Discontinuation
- 1999-08-13 AR ARP990104079A patent/AR021770A1/es not_active Application Discontinuation
- 1999-08-16 ZA ZA9905212A patent/ZA995212B/xx unknown
- 1999-08-16 MY MYPI99003508A patent/MY133133A/en unknown
- 1999-08-16 YU YU38699A patent/YU38699A/sh unknown
- 1999-08-16 JP JP22965899A patent/JP3455142B2/ja not_active Expired - Fee Related
- 1999-08-16 ID IDP990791A patent/ID23107A/id unknown
- 1999-08-16 SG SG9903973A patent/SG82014A1/en unknown
- 1999-08-16 HU HU9902737A patent/HUP9902737A3/hu unknown
- 1999-08-17 MA MA25736A patent/MA26677A1/fr unknown
- 1999-08-17 PL PL99334949A patent/PL334949A1/xx not_active Application Discontinuation
- 1999-08-17 AU AU44537/99A patent/AU756408B2/en not_active Ceased
- 1999-08-17 KR KR1019990033814A patent/KR100341194B1/ko not_active Expired - Fee Related
- 1999-08-17 CN CNB991179110A patent/CN1141936C/zh not_active Expired - Fee Related
- 1999-08-17 BR BR9903779-3A patent/BR9903779A/pt not_active IP Right Cessation
- 1999-08-17 NO NO993948A patent/NO993948L/no unknown
- 1999-08-18 TR TR1999/02015A patent/TR199902015A3/tr unknown
- 1999-08-18 HR HR98115484.2A patent/HRP990256A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
ID23107A (id)	2000-02-24
AU756408B2 (en)	2003-01-09
SG82014A1 (en)	2001-07-24
CN1248439A (zh)	2000-03-29
US6184236B1 (en)	2001-02-06
NO993948D0 (no)	1999-08-17
AU4453799A (en)	2000-05-04
CA2280455A1 (fr)	2000-02-18
TR199902015A2 (xx)	2000-03-21
JP3455142B2 (ja)	2003-10-14
ZA995212B (en)	2000-02-18
HRP990256A2 (en)	2000-04-30
YU38699A (sh)	2002-03-18
CN1141936C (zh)	2004-03-17
TR199902015A3 (tr)	2000-03-21
HUP9902737A2 (hu)	2000-06-28
KR20000017343A (ko)	2000-03-25
HUP9902737A3 (en)	2001-01-29
AR021770A1 (es)	2002-08-07
KR100341194B1 (ko)	2002-06-20
MY133133A (en)	2007-10-31
NZ337243A (en)	2000-12-22
HU9902737D0 (en)	1999-10-28
ATE326219T1 (de)	2006-06-15
JP2000109429A (ja)	2000-04-18
NO993948L (no)	2000-02-21
PE20000955A1 (es)	2000-09-28
BR9903779A (pt)	2000-09-19
IL131399A0 (en)	2001-01-28
DE69931316D1 (de)	2006-06-22
PL334949A1 (en)	2000-02-28

Publication	Publication Date	Title
DE69923076D1 (de)	2005-02-10	Transthorakale arzneimittelabgabevorrichtung
TR199901077A3 (tr)	1999-12-21	Ispençiyari formülasyonlar.
MA26549A1 (fr)	2004-12-20	Medicaments
BR9909681B1 (pt)	2009-05-05	estrutura de seringa.
BR0014930B1 (pt)	2009-01-13	cÂnula.
BR9706897B1 (pt)	2010-09-21	forma de dosagem farmacêutica.
TR199801629A3 (tr)	1999-10-21	Fungisidal 2 -metoksibenzofenonlar.
TR199902372A3 (tr)	2000-04-21	Sulfanilsilanlar.
NO20004196L (no)	2000-08-22	Innretninger for legemiddelavlevering
TR199800631A3 (tr)	1998-10-21	Ecza formülasyonu.
DK1466615T3 (da)	2009-08-31	Farmaceutisk præparat
NO20005179D0 (no)	2000-10-13	Medikament behandling
ES1037583Y (es)	1998-11-01	Granizadora dispensadora mejorada.
DZ3164A1 (fr)	2000-11-02	Nouvel agent pharmaceutique.
DE60029755D1 (de)	2006-09-14	Congawandschutz.
TR199501082A2 (tr)	1996-06-21	Farmasötik formülasyonlar.
IT1316059B1 (it)	2003-03-28	Depigmentanti cutanei.
IS6163A (is)	2001-11-16	Lyfjakomplex
MA26677A1 (fr)	2004-12-20	Medicaments antiparkinsoniens.
MA26604A1 (fr)	2004-12-20	Compositions pharmaceutiques.
DE69934902D1 (de)	2007-03-08	Medikament gegen drogenabhängigkeit
ITBO990358A0 (it)	1999-06-30	Elettromandrino .
NL1011488A1 (nl)	2000-09-14	Hoofdtelefoon-microfoon-combinatie.
ES1039369Y (es)	1999-05-01	Estanteria.
FI962120A7 (fi)	1996-05-20	Estramustiiniformulaatiot, joilla on parannetut farmaseuttiset ominais uudet